These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1375331)

  • 1. Determinants of cisplatin sensitivity in non-malignant non-drug-selected human T cell lines.
    Dabholkar M; Parker R; Reed E
    Mutat Res; 1992 Jun; 274(1):45-56. PubMed ID: 1375331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.
    Lee KB; Parker RJ; Bohr V; Cornelison T; Reed E
    Carcinogenesis; 1993 Oct; 14(10):2177-80. PubMed ID: 8222071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.
    Hill BT; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Bedford P
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):75-83. PubMed ID: 2380098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.
    Parker RJ; Eastman A; Bostick-Bruton F; Reed E
    J Clin Invest; 1991 Mar; 87(3):772-7. PubMed ID: 1999494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro.
    Dabholkar M; Bradshaw L; Parker RJ; Gill I; Bostick-Bruton F; Muggia FM; Reed E
    Environ Health Perspect; 1992 Nov; 98():53-9. PubMed ID: 1486863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic reversion of cisplatin resistance in human cells accompanies reduced host cell reactivation of damaged plasmid.
    Chao CC; Lee YL; Lin-Chao S
    Biochem Biophys Res Commun; 1990 Jul; 170(2):851-9. PubMed ID: 2116798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation.
    Jennerwein MM; Eastman A; Khokhar AR
    Mutat Res; 1991 Jan; 254(1):89-96. PubMed ID: 1986276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ormaplatin sensitivity/resistance in human ovarian cancer cells made resistant to cisplatin.
    Parker RJ; Vionnet JA; Bostick-Bruton F; Reed E
    Cancer Res; 1993 Jan; 53(2):242-7. PubMed ID: 8417816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell lines.
    Dabholkar M; Reed E
    Cancer Lett; 1992 Apr; 63(2):143-50. PubMed ID: 1314131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
    Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
    Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
    Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-cell reactivation of cisplatin-damaged pRSVcat in a human lymphoid cell line.
    Dabholkar M; Eastman A; Reed E
    Carcinogenesis; 1990 Oct; 11(10):1761-4. PubMed ID: 2170046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA.
    Sheibani N; Jennerwein MM; Eastman A
    Biochemistry; 1989 Apr; 28(7):3120-4. PubMed ID: 2742829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA; Hosking LK; Hill BT
    Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA.
    Chao CC; Huang SL; Huang HM; Lin-Chao S
    Mol Cell Biol; 1991 Apr; 11(4):2075-80. PubMed ID: 2005898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines.
    Johnson SW; Perez RP; Godwin AK; Yeung AT; Handel LM; Ozols RF; Hamilton TC
    Biochem Pharmacol; 1994 Feb; 47(4):689-97. PubMed ID: 8129746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
    Chao CC
    Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.
    Johnson SW; Laub PB; Beesley JS; Ozols RF; Hamilton TC
    Cancer Res; 1997 Mar; 57(5):850-6. PubMed ID: 9041185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat.
    To KK; Tong WS; Fu LW
    Lung Cancer; 2017 Jan; 103():58-65. PubMed ID: 28024697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.